Translate page

Highlights from EHA 2016:
3 CML experts give their personal perspectives

This independent educational resource is supported by a grant from Novartis Oncology

Perspectives from Prof. Michele Baccarani
Chairman of CML Working Party of European LeukemiaNet,
Founding member of the iCMLf, Università di Bologa, Italy

  • The unmet needs in CML
  • Pathways to treatment free response
  • Next generation sequencing - the impact on future treatment decision making

 {rscomments off}